FOSUN HEALTH Logo

Awards & Accreditations

Fosun Health hospitals in China hold JCI international accreditation and Grade III-A status, China's highest hospital rating, and have received 8 recent international awards and industry recognitions—the quality behind your care is verified, not promised.

Recent Honors & Recognitions

Each entry links to its official source, so you can verify every honor independently.

International Accreditations Behind Our Hospitals in China

New awards, accreditations, and industry recognitions are added here as they are announced. Each entry links to its official source so you can verify the honor independently.

Consistently Ranked Among China's Best Private Hospital Groups

Social recognitions

Parent Strength & Governance

  • Parent company Fosun Pharma is among the top ESG performers in the global pharmaceutical industry.

  • Ranked among the top 10 in China's pharmaceutical industry ranking for eight consecutive years.

  • Ranked No. 1 in China for international multi-center clinical trial projects and country coverage.

  • China's first CAR-T and the world's first solid-tumor CAR-T are used at our hospitals.

  • SSE 600196 & HKEX 02196—audited, disclosed, and accountable.

The accreditations above are supported by the governance, compliance, and research infrastructure of our parent company—see Our Parent Company– Fosun Pharma

What These Accreditations Mean for Your Care

Accreditations are not certificates on a wall—they can translate into four practical benefits throughout your treatment journey at our hospitals in China.

  • JCI, Grade III-A, and ISO certifications are independently audited and publicly verifiable — following the same standards used to evaluate hospitals worldwide.

  • National GCP certification means our hospitals are licensed to conduct drug and medical device clinical trials—with seven network hospitals holding GCP certification, your doctors practice at the forefront of evidence-based care.

  • Through the Hong Kong and Macau Drug and Device Access Policy and our parent company's pharmaceutical pipeline, patients can access innovative drugs and devices—including CAR-T therapies—often before they reach other markets.

  • Our flagship hospital holds all five national major center qualifications—chest pain, stroke, trauma, critical maternal rescue, and critical newborn rescue— enabling around-the-clock rapid-response pathways.

Frequently Asked Questions

Are Fosun Health hospitals in China accredited?

Yes. Our flagship hospital is a Grade III-A hospital (China's highest hospital rating) that has passed two rounds of JCI international accreditation with high scores. The network also holds ISO 15189 and ISO 9001 laboratory certifications, national GCP (drug clinical trial) certification, with seven hospitals holding GCP certification, all five national major clinical center qualifications, 76 key specialties across the network, and the Hong Kong and Macau Drug and Device Access Policy designated status.

What international awards has Fosun Health won?

At the 11th GlobalHealth Asia Pacific Forum in Jakarta (April 2026), Fosun Health won Oncology Service Provider of the Year – Asia Pacific, and Foshan Fosun Chancheng Hospital won both Hospital of the Year – China and TCM Hospital of the Year – Asia Pacific — three international awards in a single year.

What does the Grade III-A hospital rating mean in China?

China classifies hospitals into three tiers; Grade III-A is the highest level, awarded based on clinical capability, medical quality, safety, teaching, and research. Foshan Fosun Chancheng Hospital holds this rating as a large-scale comprehensive tertiary hospital—providing assurance for high-complexity treatments such as tumor surgery, robotic surgery, and CAR-T therapy.

Is Fosun Health one of the top private hospital groups in China?

Yes. Fosun Health ranked No. 2 in the 2024–2025 Ailibi China Private Hospital Group 100 and has remained among the top 3 for five consecutive years. Its flagship hospital has been No. 1 among private single hospitals for eight consecutive years (2018–2025), and nine member hospitals were included in the China Private Hospital Top 500.

How do these accreditations benefit international patients?

They provide independently verifiable assurance: JCI and Grade III-A for clinical safety, ISO-certified laboratories for reliable diagnostics, GCP for evidence-based medicine, and Hong Kong and Macau Drug and Device Access Policy for access to global innovative drugs. For more details on our network, see Our Hospitals & Facilities.

Experience Care That's Independently Verified

From JCI accreditation to three GlobalHealth Awards, our quality is independently confirmed. Let our international team arrange your consultation at an accredited Fosun Health hospital.

Book a Consultation Our Hospitals & Facilities Our Parent Company

Follow Fosun Health

Apply for an Appointment

Do you have test results*